U.S. Health Care REITs Stock News

Amicus Therapeutics (FOLD) closed out FY 2025 with Q4 revenue of US$185.2 million and basic EPS of US$0.01, alongside net income excluding extra items of US$1.7 million, giving investors fresh data on how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$149.7 million in Q4 2024 to US$185.2 million in Q4 2025, while basic EPS shifted from US$0.05 to US$0.01 over the same period, creating a mixed picture on profitability trends. With...

If you are wondering whether Jackson Financial's current share price really reflects its value, you are not alone and this article is here to unpack that question clearly. The stock most recently closed at US$113.74, with returns of 1.5% over the last 7 days, 3.0% over 30 days, 5.8% year to date, 38.0% over 1 year and 176.8% over 3 years. This naturally raises questions about how much of this performance is already priced in. Recent coverage has focused on Jackson Financial as investors...

LCI Industries recently reported strong results, pointing to firm demand for RV components and active production across the sector. This contrasts with Camping World Holdings' recent earnings, which highlight financial and operational pressure, including debt and weaker cash generation. Investors are weighing robust supplier data against company specific headwinds at Camping World Holdings, NYSE:CWH. For Camping World Holdings, NYSE:CWH, the latest sector read through from LCI Industries...

Franklin Electric (NasdaqGS:FELE) is rolling out a value acceleration office focused on operational improvements supported by artificial intelligence tools. The company is using AI-driven initiatives to refine processes and cost management across its operations. Franklin Electric has also raised its quarterly dividend, reinforcing its pattern of returning cash to shareholders. Franklin Electric, known for its water and fueling systems, is pushing into more data driven operations as it looks...

Cullen/Frost Bankers (NYSE:CFR) highlights a robust dividend record, with a pattern of regular increases that outpaces many peers. The company presents this dividend profile as evidence of sustained financial strength and a positive outlook for future earnings. The bank indicates potential for further dividend growth, reinforcing its appeal for income focused shareholders. Cullen/Frost Bankers, a Texas based regional bank, is putting its dividend front and center at a time when many...

As the U.S. stock market kicks off February with a robust performance, highlighted by significant gains in major indices such as the Dow Jones Industrial Average and S&P 500, investors are closely watching the tech sector for potential high-growth opportunities. In this dynamic environment, identifying promising tech stocks involves considering factors like innovation, market demand, and adaptability to current economic conditions.

As February begins, the U.S. stock market has shown notable strength with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting optimism among investors despite ongoing economic uncertainties. In such a vibrant market environment, identifying undervalued stocks can be particularly appealing as they may offer potential for growth at a discounted price.

As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...

Why CureVac's latest trial milestone matters for shareholders CureVac (CVAC) has completed a Phase 1 clinical study for its CVGBM mRNA based brain cancer vaccine in patients with surgically resected glioblastoma or astrocytoma, marking a key early checkpoint for its oncology pipeline. See our latest analysis for CureVac. The completion of the CVGBM Phase 1 study comes after a sharp 14.32% 1 day share price decline and a 19.18% 7 day share price return. However, CureVac’s year to date share...

Artivion, Inc.'s ( NYSE:AORT ) earnings announcement last week was disappointing for investors, despite the decent...

Investors signalled that they were pleased with Cognex Corporation's ( NASDAQ:CGNX ) most recent earnings report. This...

It looks like Johnson & Johnson ( NYSE:JNJ ) is about to go ex-dividend in the next 4 days. The ex-dividend date occurs...

Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Even though DexCom, Inc.'s ( NASDAQ:DXCM ) recent earnings release was robust, the market didn't seem to notice. Our...

As February 2026 begins, U.S. stock markets have shown resilience with major indices like the Dow Jones and S&P 500 ending sharply higher, buoyed by positive economic indicators such as an unexpected expansion in factory activity. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking value and growth potential, especially when insider actions suggest confidence in a company's prospects amidst broader market optimism.

As February 2026 begins, the U.S. stock market shows a robust start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this environment of renewed optimism, identifying stocks that may be trading below their estimated value can offer intriguing opportunities for investors looking to capitalize on potential growth amid favorable market conditions.

The market was pleased with the recent earnings report from Insight Enterprises, Inc. ( NASDAQ:NSIT ), despite the...

As February begins, the U.S. stock market is showing strength, with major indexes like the Dow Jones and S&P 500 posting significant gains. In this context of rising indices, investors often look for opportunities that may offer growth potential at a lower entry cost. Penny stocks, though considered a niche investment area today, still hold promise by offering access to smaller or newer companies that can potentially deliver strong returns when backed by solid financials. Let's explore...

As February begins, U.S. stock indexes have shown strength, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing a record high. In this dynamic market environment, dividend stocks can offer stability and income potential, making them an appealing consideration for investors seeking to balance growth with consistent returns.

If you are wondering whether OPENLANE's current share price lines up with its underlying worth, you are not alone. This article is built to unpack that question step by step. OPENLANE closed at US$29.10, with returns of 1.5% over the last 7 days, a 3.4% decline over 30 days, marginally lower at 0.4% decline year to date, and a 45.0% return over 1 year, 89.3% over 3 years, and 93.6% over 5 years, which may prompt you to ask whether the recent journey still lines up with fair value. Recent...

Some Saia, Inc. ( NASDAQ:SAIA ) shareholders may be a little concerned to see that the Executive VP & Chief Customer...

The analysts covering Forrester Research, Inc. ( NASDAQ:FORR ) delivered a dose of negativity to shareholders today, by...

United Fire Group, Inc. ( NASDAQ:UFCS ) stock is about to trade ex-dividend in 4 days. The ex-dividend date occurs one...

Some Loews Corporation ( NYSE:L ) shareholders may be a little concerned to see that insider Andrew Tisch recently sold...